Boston Scientific says cyberattack may disrupt guidance delivery
Boston Scientific said it likely won’t meet its financial guidance due to a cyberattack that has disrupted operations, with shares down sharply in premarket trading.
Boston Scientific said it likely won't meet its financial guidance because of the cyberattack that has disrupted its operations, sending shares of the medical-technology company sharply lower in premarket trading. On Tuesday, Boston Scientific said it continues to make progress in restoring its systems.